Effect of extract from Yiyuan Yiliu Tang on human lung adenocarcinoma and human hepatoma cell lines.

Yi, Qingqing; Cai, Weiwei; Chang, Qing; Liang, Dongyu; Yang, Rong; Jiang, Guowei; Qiu, Liying

Yi, Qingqing; Cai, Weiwei; Chang, Qing; Liang, Dongyu; Yang, Rong; Jiang, Guowei; Qiu, Liying.

Affiliation

Yi Q; Clinical Research Center, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
Cai W; Department of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi 214122, China.
Chang Q; Clinical Research Center, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
Liang D; Clinical Research Center, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
Yang R; Pathology department, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
Jiang G; Departments of Pharmacy, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai 201800, China.
Qiu L; Department of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi 214122, China.

J Tradit Chin Med ; 41(1): 36-43, 2021 02.

Article de En | MEDLINE | ID: mdl-33522195

Sujet(s)
Mots clés

Antineoplastic agent; Apoptosi; Cell cycle; Nodal protein; Yiyuan Yiliu Tang

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Médicaments issus de plantes chinoises / Adénocarcinome pulmonaire / Tumeurs du poumon / Antinéoplasiques d'origine végétale Limites: Humans Langue: En Journal: J Tradit Chin Med Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google